U.S. News & World Report: Report questions expanded Ohio inmate electronic monitoring
A report commissioned by Ohio Gov. Mike DeWine and presented this month by researchers at the University of Cincinnati finds limited evidence that expanding electronic monitoring of Ohio inmates would reduce the rates at which ex-offenders commit new crimes or that it would enhance public safety. The report, conducted by researchers with the UC Corrections Institute, also found that creating a system to allow real-time monitoring of convicts would be unlikely in keeping them from committing additional crimes. DeWine commissioned the report as part of a state taskforce studying offender supervision programs.
Read the story here
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.